These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9215736)
1. A simple and reliable method for screening retroviral producer clones without selectable markers. Onodera M; Yachie A; Nelson DM; Welchlin H; Morgan RA; Blaese RM Hum Gene Ther; 1997 Jul; 8(10):1189-94. PubMed ID: 9215736 [TBL] [Abstract][Full Text] [Related]
2. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098 [TBL] [Abstract][Full Text] [Related]
3. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression. Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874 [TBL] [Abstract][Full Text] [Related]
4. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers. Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069 [TBL] [Abstract][Full Text] [Related]
5. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hanazono Y; Yu JM; Dunbar CE; Emmons RV Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126 [TBL] [Abstract][Full Text] [Related]
6. Reliable generation of stable high titer producer cell lines for gene therapy. Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445 [TBL] [Abstract][Full Text] [Related]
7. A rapid screening procedure for the identification of high-titer retrovirus packaging clones. Murdoch B; Pereira DS; Wu X; Dick JE; Ellis J Gene Ther; 1997 Jul; 4(7):744-9. PubMed ID: 9282176 [TBL] [Abstract][Full Text] [Related]
8. Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay. Green BJ; Rasko JE Hum Gene Ther; 2002 Jun; 13(9):1005-13. PubMed ID: 12067434 [TBL] [Abstract][Full Text] [Related]
9. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene. Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335 [TBL] [Abstract][Full Text] [Related]
10. Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector. Zaboikin MM; Schuening FG Hum Gene Ther; 1998 Oct; 9(15):2263-75. PubMed ID: 9794210 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors. Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311 [TBL] [Abstract][Full Text] [Related]
13. Construction of retroviral vectors carrying human CD3 gamma cDNA and reconstitution of CD3 gamma expression and T cell receptor surface expression and function in a CD3 gamma-deficient mutant T cell line. Sun JY; Pacheco-Castro A; Borroto A; Alarcon B; Alvarez-Zapata D; Regueiro JR Hum Gene Ther; 1997 Jun; 8(9):1041-8. PubMed ID: 9189762 [TBL] [Abstract][Full Text] [Related]
14. Recovery of a rare clone from a population of unstable retroviral vector-expressing mammalian cells using a new RNA extraction and slot-blot protocol. Bennett SA; Chen JH; Birnboim HC J Virol Methods; 1994 Dec; 50(1-3):245-55. PubMed ID: 7714048 [TBL] [Abstract][Full Text] [Related]
15. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression. Couture LA; Mullen CA; Morgan RA Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129 [TBL] [Abstract][Full Text] [Related]
16. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581 [TBL] [Abstract][Full Text] [Related]
17. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259 [TBL] [Abstract][Full Text] [Related]
18. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Lin X Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327 [TBL] [Abstract][Full Text] [Related]
19. Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies. Xiao M; Yang YC; Yang L; Chang MS; Cornetta K; Broxymeyer HE; Lu L Bone Marrow Transplant; 1996 Dec; 18(6):1103-9. PubMed ID: 8971379 [TBL] [Abstract][Full Text] [Related]